文献速递头颈外科

新诊断头颈癌患者恐惧癌症复发的前瞻性纵向研究:病程、轨迹及相关因素

Prospective longitudinal study on fear of cancer recurrence in patients newly diagnosed with head and neck cancer: Course, trajectories, and associated factors.
PubMed 文献 · Head Neck · 2022-01-27

基于NET-QUBIC队列617例新诊断头颈癌患者,在诊断时、治疗后3个月和6个月完成癌症担忧量表-6,采用潜在类别增长分析识别恐惧癌症复发轨迹。恐惧癌症复发整体从基线至治疗后3个月轻微下降,至6个月保持稳定;识别出「高稳定」(n=125)和「低下降」(n=492)两种轨迹。高稳定轨迹患者更年轻、负性适应更多、被动应对和安慰性想法更多、回避更少。

要点

  • 多数头颈癌患者诊断后恐惧癌症复发呈低水平下降轨迹。
  • 约五分之一患者恐惧癌症复发持续高水平至治疗后6个月。
  • 高稳定恐惧癌症复发与年轻、负性适应、被动应对和安慰性想法相关。

核心结论

  • 多数头颈癌患者诊断后恐惧癌症复发水平低且下降,但约五分之一患者至治疗后6个月仍持续高恐惧癌症复发。

研究设计与样本

  • 前瞻性纵向研究,纳入NET-QUBIC队列中617例新诊断头颈癌患者,在诊断时、治疗后3个月和6个月完成癌症担忧量表-6,采用潜在类别增长分析识别恐惧癌症复发轨迹。

主要发现

  • 恐惧癌症复发整体从基线至治疗后3个月轻微下降,至6个月保持稳定。
  • 识别出两种恐惧癌症复发轨迹:「高稳定」(n=125)和「低下降」(n=492)。
  • 高稳定恐惧癌症复发患者更年轻,报告更多负性适应、被动应对和安慰性想法,回避更少。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study assessed the course of fear of cancer recurrence (FCR) in patients newly diagnosed with head and neck cancer (HNC), identified FCR trajectories and factors associated with FCR trajectories. METHODS: Six hundred and seventeen HNC patients from the NET-QUBIC cohort study completed the Cancer Worry Scale-6 at diagnosis, 3 and 6 months post-treatment. FCR trajectories were identified using Latent Class Growth Analysis. Associations were explored between FCR trajectories and baseline demographic and medical variables, coping and self-efficacy. RESULTS: Overall, FCR decreased slightly between baseline and 3 months post-treatment and remained stable up to 6 months. Two FCR trajectories were identified: "high stable" (n = 125) and "low declining" (n = 492). Patients with high stable FCR were younger, reported more negative adjustment, passive coping, and reassuring thoughts, and less avoidance. CONCLUSIONS: The majority of HNC patients have low declining FCR after diagnosis, but one in five patients experience persistent high FCR up to 6 months post-treatment.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Deuning-Smit E, Custers JAE, Miroševič Š, et al. Prospective longitudinal study on fear of cancer recurrence in patients newly diagnosed with head and neck cancer: Course, trajectories, and associated factors. Head Neck. 2022. PMID: 35084079. doi:10.1002/hed.26985

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。